Search Within

Population Sciences Research Program

  1. "Mark Kris"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (39)
Groups
  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (82)
  3. Thoracic Oncology (82)
  4. Epidemiology and Biostatistics (70)
  5. Biostatistics Service (59)
  6. GSK Faculty (33)

More Groups

People
  1. Mark Kris (82)
  2. Ronglai Shen (38)
  3. Marc Ladanyi (24)
  4. Gregory Riely (21)
  5. Valerie Rusch (19)
  6. Charles Rudin (17)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (7)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Journal of Thoracic Oncology (16)
  3. Clinical Cancer Research (7)
  4. Cancer (2)
  5. Cancer Discovery (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Elsevier Inc. (18)
  3. American Association for Cancer Research (11)
  4. Elsevier Science, Inc. (3)
  5. Oxford University Press (3)
  6. Springer (3)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • "A tool, not a crutch": Patient perspectives about IBM Watson for Oncology trained by Memorial Sloan Kettering
    Journal Article

    Hamilton, J. G.; Genoff Garzon, M.; Westerman, J. S.; Shuk, E.; Hay, J. L.; Walters, C.; Elkin, E.; Bertelsen, C.; Cho, J.; Daly, B.; more...
    Journal of Oncology Practice (2019)

    Fulltext@MSK | Save
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
    Meeting Abstract

    Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save